| Phase 1/2 |
| NCT07068555 |
Prostate Cancer Vaccines |
Prostate Cancer Indications |
Recruiting |
| NCT02992210 |
Study on GD2 Positive Solid Tumors by 4SCAR-GD2 |
Solid Tumor |
Recruiting |
| NCT03184753 |
Genetically Modified T Cells Against Ovarian Cancer |
Ovarian Cancer |
Recruiting |
| NCT06739226 |
Combination Immunotherapy Targeting Melanoma |
Melanoma |
Recruiting |
| NCT07180927 |
DLL3 CAR-T Therapy Targeting Brain Tumors |
Glioblastoma of Cerebellum |
Recruiting |
| NCT07193966 |
NG2 and DLL3 CAR-T Cells Targeting Melanoma |
Melanoma |
Recruiting |
| NCT07477600 |
cfMSC Stem Cell Therapy Targeting COPD |
Chronic Obstructive Pulmonary Disease (COPD) |
Recruiting |
| NCT07495956 |
cfMSC Therapy for Diabetes |
Type II Diabetes Mellitus |
Recruiting |
| NCT07501156 |
H3K27M-specific Immune Effector Cells Targeting DMG/DIPG |
Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma |
Recruiting |
| NCT03159364 |
Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections |
Pathogen Infection |
Recruiting |
| NCT03535246 |
Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells |
Cancer |
Recruiting |
| NCT03614650 |
Immunotherapy Treating GI Cancer |
Cancer |
Recruiting |
| NCT04637503 |
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma |
Neuroblastoma |
Recruiting |
| NCT03050190 |
A Phase I/II Multiple Center Trial of 4SCAR19 Cells in the Treatment of Relapsed and… |
B-cell Malignancies |
Recruiting |
| NCT03125577 |
Combination CAR-T Cell Therapy Targeting Hematological Malignancies |
B-cell Malignancies |
Recruiting |
| NCT03185468 |
Intervention of Bladder Cancer by CAR-T |
Bladder Cancer |
Recruiting |
| NCT03217617 |
SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection |
SCID, X-Linked |
Recruiting |
| NCT03222674 |
Multi-CAR T Cell Therapy for Acute Myeloid Leukemia |
Acute Myeloid Leukemia |
Recruiting |
| NCT03271632 |
Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma |
Multiple Myeloma |
Recruiting |
| NCT03351855 |
HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV |
Human Papilloma Virus |
Recruiting |
| NCT03356782 |
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting… |
Sarcoma |
Recruiting |
| NCT03356795 |
Intervention of CAR-T Against Cervical Cancer |
Cervical Cancer |
Recruiting |
| NCT03356808 |
Antigen-specific T Cells Against Lung Cancer |
Lung Cancer |
Recruiting |
| NCT03362606 |
Engineered Immune Effectors Against Ovarian Cancer |
Ovarian Cancer |
Recruiting |
| NCT03362619 |
Engineered Immune Effectors Against Cervical Cancer |
Cervical Cancer |
Recruiting |